COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,635 Articles (22,913 medRxiv, 8,722 bioRxiv)

Most recent first Previous |  Page 1240: Articles 12391-12400  | Next

Acute COVID-19 gene-expression profiles show multiple etiologies of long-term sequelae
Thompson, R. C., Simons, N. W., Wilkins, L., Cheng, E., Del-Valle, D. M., Hoffman, G. E., Fennessy, B., Mouskas, K., Francoeur, N. J., Johnson, J. S., Lepow, L., Le Berichel, J., Chang, C., Beckmann, A. G., Wang, Y.-c., Nie, K., Zaki, N., Tuballes, K., Barcessat, V., Cedillo, M. A., Huckins, L., Roussos, P., Marron, T. U., The Mount Sinai COVID-19 Biobank Team, , Glicksberg, B. S., Nadkarni, G., Gonzalez-Kozlova, E., Kim-Schulze, S., Sebra, R., Merad, M., Gnjatic, S., Schadt, E. E., Charney, A. W., Beckmann, N. D.
10.1101/2021.10.04.21264434 — Posted: 2021-10-05
Adverse events following COVID-19 vaccination in young Japanese people: A case-control study of the risk of systemic adverse events by a questionnaire surveyShort title: COVID-19 vaccine adverse events in young Japanese
Suehiro, M., Okubo, S., Nakajima, K., Kanda, K., Hayakawa, M., Oiso, S., Kabashima, T., Fujita, H., Ando, Y., Muro, T.
10.1101/2021.10.01.21264393 — Posted: 2021-10-05
Increase in preterm stillbirths and reduction in iatrogenic preterm births for fetal compromise: a multi-centre cohort study of COVID-19 lockdown effects in Melbourne, Australia
Hui, L., Marzan, M. B., Potenza, S., Rolnik, D. L., Pritchard, N., Said, J. M., Palmer, K. R., Whitehead, C. L., Sheehan, P. M., Ford, J., Mol, B. W., Walker, S. P.
10.1101/2021.10.04.21264500 — Posted: 2021-10-05 Discussion: Onsite
Circulating proteins to predict adverse COVID-19 outcomes
Su, C.-Y., Zhou, S., Gonzalez-Kozlova, E., Butler-Laporte, G., Brunet-Ratnasingham, E., Nakanishi, T., Jeon, W., Morrison, D., Laurent, L., Afilalo, J., Afilalo, M., Henry, D., Chen, Y., Carrasco-Zanini, J., Farjoun, Y., Pietzner, M., Kimchi, N., Afrasiabi, Z., Rezk, N., Bouab, M., Petitjean, L., Guzman, C., Xue, X., Tselios, C., Vulesevic, B., Adeleye, O., Abdullah, T., Almamlouk, N., Moussa, Y., DeLuca, C., Duggan, N., Schurr, E., Brassard, N., Durand, M., Marie Del Valle, D., Thompson, R., Cedillo, M. A., Schadt, E., Nie, K., Simons, N. W., Mouskas, K., Zaki, N., Patel, M., Xie, H., Harris, J., Marvin, R., Cheng, E., Tuballes, K., Argueta, K., Scott, I., The Mount Sinai COVID Biobank Team, , Greenwood, C. M. T., Paterson, C., Hinterberg, M., Langenberg, C., Forgetta, V., Pineau, J., Mooser, V., Marron, T., Beckmann, N., Kenigsberg, E., Kim-schulze, S., Charney, A. W., Gnjatic, S., Kaufmann, D. E., Merad, M., Richards, J. B.
10.1101/2021.10.04.21264015 — Posted: 2021-10-05
Use of an EHR to inform an administrative data algorithm to categorize inpatient COVID-19 severity
Garry, E. M., Weckstein, A. R., Quinto, K., Lasky, T., Chakravarty, A., Leonard, S., Vititoe, S. E., Easthausen, I. J., Rassen, J. A., Gatto, N. M.
10.1101/2021.10.04.21264513 — Posted: 2021-10-05
Adverse events of special interest for COVID-19 vaccines - background incidences vary by sex, age and time period and are affected by the pandemic
Nyberg, F., Lindh, M., Vanfleteren, L. E., Hammar, N., Wettermark, B., Sundström, J., Santosa, A., Kirui, B. K., Gisslen, M.
10.1101/2021.10.04.21263507 — Posted: 2021-10-05 Discussion: Onsite
Acquisition and onward transmission of a SARS-CoV-2 E484K variant among household contacts of a bamlanivimab-treated patient
Sabin, A. P., Richmond, C. S., Kenny, P. A.
10.1101/2021.10.02.21264415 — Posted: 2021-10-05 Discussion: Onsite
Year-long COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B cell depletion
Ghedin, E., Nussenblatt, V., Roder, A., Das, S., de Wit, E., Youn, J.-H., Banakis, S., Muchegian, A., Mederos, C., Wang, W., Chung, M., Perez-Perez, L., Palmore, T., Brudno, J., Kochenderfer, J.
10.1101/2021.10.02.21264267 — Posted: 2021-10-05
De Novo Whole Genome Assembly of the Roborovski Dwarf Hamster (Phodopus roborovskii) Genome, an Animal Model for Severe/Critical COVID-19
Andreotti, S., Altmüller, J., Quedenau, C., Borodina, T., Nouailles, G., Teixeira Alves, L. G., Landthaler, M., Bieniara, M., Trimpert, J., Wyler, E.
10.1101/2021.10.02.462569 — Posted: 2021-10-04
Humoral immune responses to COVID-19 vaccination in people living with HIV on suppressive antiretroviral therapy
Brumme, Z. L., Mwimanzi, F. M., Lapointe, H. R., Cheung, P., Sang, Y., Duncan, M. C., Yaseen, F., Agafitei, O., Ennis, S., Ng, K., Basra, S., Lim, L. Y., Kalikawe, R., Speckmaier, S., Moran-Garcia, N., Young, L., Ali, H., Ganase, B., Umviligihozo, G., Omondi, F. H., Atkinson, K., Sudderuddin, H., Toy, J., Sereda, P., Burns, L., Costiniuk, C. T., Cooper, C., Anis, A. H., Leung, V., Holmes, D., DeMarco, M. L., Simons, J., Hedgcock, M., Romney, M. G., Barrios, R., Guillemi, S., Brumme, C. J., Pantophlet, R., Montaner, J. S. G., Niikura, M., Harris, M., Hull, M., Brockman, M. A.
10.1101/2021.10.03.21264320 — Posted: 2021-10-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).